Search research articles
Contact Us
Filters
Showing results (181-190 of 305) with videos related to
Page
of 31
Sort By:
Inquiry : a Journal of Medical Care Organization, Provision and Financing
|
January 1, 1986
The role of specialized clinical services in competition among hospitals
H S Luft, J C Robinson, D W Garnick, et al.
Urology
|
October 1, 1996
Leydig cell hyperplasia mimicking testicular neoplasm
A F Olumi, M B Garnick, A A Renshaw, et al.
Clinical Pharmacology and Therapeutics
|
April 24, 2003
Pharmacokinetics and pharmacodynamics of abarelix, a gonadotropin-releasing hormone antagonist, after subcutaneous continuous infusion in patients with prostate cancer
Shekman L Wong, David T-W Lau, Sharon A Baughman, et al.
Urology
|
November 17, 2001
A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer
D McLeod, N Zinner, K Tomera, et al.
Medical Care
|
November 1, 1988
Hospital volume and patient outcomes. The case of hip fracture patients
R G Hughes, D W Garnick, H S Luft, et al.
Radiology
|
September 1, 1991
CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded?
P C Stomper, L A Kalish, M B Garnick, et al.
Blood
|
February 15, 1990
In vivo hematologic effects of recombinant human macrophage colony-stimulating factor
T R Ulich, J del Castillo, L R Watson, et al.
BJU International
|
July 6, 2013
The utility of prostate-specific antigen in the management of advanced prostate cancer
E David Crawford, Charles L Bennett, Gerald L Andriole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1988
Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology
C Y Fung, L A Kalish, G L Brodsky, et al.
Journal of Substance Abuse Treatment
|
June 26, 2009
The Washington Circle continuity of care performance measure: predictive validity with adolescents discharged from residential treatment
Bryan R Garner, Mark D Godley, Rodney R Funk, et al.
Page
of 31
Search research articles
Search
Showing results (181-190 of 305) with videos related to
Sort By:
Page
of 31
Inquiry : a Journal of Medical Care Organization, Provision and Financing
|
January 1, 1986
The role of specialized clinical services in competition among hospitals
H S Luft, J C Robinson, D W Garnick, et al.
Urology
|
October 1, 1996
Leydig cell hyperplasia mimicking testicular neoplasm
A F Olumi, M B Garnick, A A Renshaw, et al.
Clinical Pharmacology and Therapeutics
|
April 24, 2003
Pharmacokinetics and pharmacodynamics of abarelix, a gonadotropin-releasing hormone antagonist, after subcutaneous continuous infusion in patients with prostate cancer
Shekman L Wong, David T-W Lau, Sharon A Baughman, et al.
Urology
|
November 17, 2001
A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer
D McLeod, N Zinner, K Tomera, et al.
Medical Care
|
November 1, 1988
Hospital volume and patient outcomes. The case of hip fracture patients
R G Hughes, D W Garnick, H S Luft, et al.
Radiology
|
September 1, 1991
CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded?
P C Stomper, L A Kalish, M B Garnick, et al.
Blood
|
February 15, 1990
In vivo hematologic effects of recombinant human macrophage colony-stimulating factor
T R Ulich, J del Castillo, L R Watson, et al.
BJU International
|
July 6, 2013
The utility of prostate-specific antigen in the management of advanced prostate cancer
E David Crawford, Charles L Bennett, Gerald L Andriole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1988
Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology
C Y Fung, L A Kalish, G L Brodsky, et al.
Journal of Substance Abuse Treatment
|
June 26, 2009
The Washington Circle continuity of care performance measure: predictive validity with adolescents discharged from residential treatment
Bryan R Garner, Mark D Godley, Rodney R Funk, et al.
Page
of 31